Hajdu Cheney Syndrome; report of a novel NOTCH2 mutation and treatment with denosumab.

Abstract excerpt

Notch receptors play a central role in skeletal development and homeostasis. Hajdu Cheney Syndrome (HCS) is a rare disease associated with mutations of NOTCH2 that lead to the translation of a truncated, presumably stable, NOTCH2 protein. As a consequence, a gain-of-NOTCH2 function is manifested. We report a subject presenting with HCS and her child, both harboring a new heterozygous mutation in Exon 34 of NOTCH2...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Treatment Outcome
• Share to Bone Density Conservation Agents